Loading...
Loading...
- Preliminary Q1 reports EPS $0.17 vs. $0.20 estimate; Chair, President and CEO Michael Barnes resigned
- Received Grand Jury subpoena from Department of Justice; internal control over financial reporting was ineffective
- Revenue $402.1 million vs. $415.1 million estimate
- Outpatient prescription covered down over 200 per week and hospital units sold down over 80 units per week
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in